OTCMKTS:CURLF

Curaleaf (CURLF) Stock Forecast, Price & News

$4.25

+0.02 (+0.47%)

(As of 09/26/2023 ET)

Compare

Today's Range: $4.12
▼
$4.52
50-Day Range: $2.69
▼
$5.39
52-Week Range: $2.19
▼
$7.90

Volume: 1.47 million shs
Average Volume: 1.34 million shs
Market Capitalization: $2.68 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.00

Profile Analyst Ratings Chart Competitors Earnings Financials Headlines SEC Filings Short Interest

Curaleaf MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.73 Rating Score
Upside/Downside: 205.9% Upside
$13.00 Price Target
Short Interest: Healthy
0.43% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.31
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.24) to ($0.13) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.98 out of 5 stars

3.4

Analyst's Opinion

Consensus Rating
Curaleaf has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 9 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $13.00, Curaleaf has a forecasted upside of 205.9% from its current price of $4.25.
Amount of Analyst Coverage
Curaleaf has only been the subject of 4 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.43% of the outstanding shares of Curaleaf have been sold short.
Short Interest Ratio / Days to Cover
Curaleaf has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Curaleaf has recently decreased by 12.98%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Curaleaf does not currently pay a dividend.
Dividend Growth
Curaleaf does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CURLF.

1.5

News and Social Media Coverage

News Sentiment
Curaleaf has a news sentiment score of -0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Consumer Discretionary companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Curaleaf this week, compared to 3 articles on an average week.
Search Interest
14 people have searched for CURLF on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.
MarketBeat Follows
Only 18 people have added Curaleaf to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Curaleaf insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.04% of the stock of Curaleaf is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Curaleaf are expected to grow in the coming year, from ($0.24) to ($0.13) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Curaleaf is -7.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Curaleaf is -7.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Curaleaf has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Curaleaf (OTCMKTS:CURLF) Stock

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

CURLF Price History

30 days | 90 days | 365 days | Advanced Chart

CURLF Stock News Headlines

September 26, 2023 | msn.com

Curaleaf Executive Chairman: I think we're gonna get a positive bipartisan vote from the Senate

September 24, 2023 | americanbankingnews.com

True Drinks (OTCMKTS:TRUU) versus Curaleaf (OTCMKTS:CURLF) Critical Comparison

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.

September 21, 2023 | markets.businessinsider.com

MSO Financial Health: Debt Restructuring Vs. Equity Raises – Analyst Digs Into Spreadsheets

September 20, 2023 | bizjournals.com

Curaleaf employees stage first cannabis worker strike in Arizona history

September 16, 2023 | news.yahoo.com

Curaleaf's Dispensary Midtown employees hold strike Friday, demanding transparency

September 15, 2023 | msn.com

Why Canopy Growth, Aurora Cannabis, Cresco Labs, and Curaleaf Stocks All Popped

September 8, 2023 | msn.com

3 Top Cannabis Stocks to Buy for September

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

September 5, 2023 | benzinga.com

EXCLUSIVE: Curaleaf Chairman Predicts DEA's Future Steps On Cannabis Rescheduling

September 5, 2023 | benzinga.com

Weed-Infused Beverage By Curaleaf Hits The Shelves, Here's Where You Can Find It

August 31, 2023 | markets.businessinsider.com

Why Curaleaf Holdings Stock Is Moving Higher

August 31, 2023 | proactiveinvestors.com

Cannabis stocks on fire as US health department calls for easing restrictions

August 30, 2023 | barrons.com

Tilray and Curaleaf Stocks Surge as DEA Considers Reclassifying Marijuana

August 29, 2023 | finance.yahoo.com

Curaleaf Celebrates Launch of Adult Use Sales at Manchester, CT Dispensary

August 21, 2023 | benzinga.com

Curaleaf Launches Adult Use Cannabis Sales At Manchester, CT Dispensary

August 21, 2023 | benzinga.com

Curaleaf Poised To Dominate German Cannabis Market As Government Moves To Legalize

August 16, 2023 | msn.com

Waiting to Buy Marijuana Stocks After Legalization Could Be a Costly Mistake

August 11, 2023 | benzinga.com

Curaleaf's Boris Jordan: No Capital Raises Planned, Company Has $50M In Revolving Credit

August 10, 2023 | finanznachrichten.de

Curaleaf Holdings, Inc.: Curaleaf Reports Second Quarter 2023 Results

August 10, 2023 | finance.yahoo.com

Curaleaf's Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

August 9, 2023 | finance.yahoo.com

Curaleaf Holdings, Inc. (CURLF) Reports Q2 Loss, Misses Revenue Estimates

August 9, 2023 | finance.yahoo.com

Curaleaf Reports Second Quarter 2023 Results

August 8, 2023 | benzinga.com

Earnings Outlook For Curaleaf Holdings

July 20, 2023 | benzinga.com

Cannabis Giant Curaleaf Trims Workforce in New Jersey Amid Market Glut

July 12, 2023 | benzinga.com

New Mobile App For Cannabis Users To Order Favorite Products, Read About Discounts And More

July 12, 2023 | finance.yahoo.com

Curaleaf to Report Second Quarter 2023 Financial and Operational Results

See More Headlines

Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

CURLF Company Calendar

Last Earnings: 8/09/2023
Today: 9/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medicinals & botanicals
Sub-Industry: N/A
Sector: Consumer Discretionary
Current Symbol: OTCMKTS:CURLF
CUSIP: N/A
CIK: 1756770
Web: www.curaleaf.com
Phone: 781-451-0351
Fax: N/A
Employees: 5,931
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $13.00
High Stock Price Forecast: $32.25
Low Stock Price Forecast: $4.25
Forecasted Upside/Downside: +205.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.73
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.60)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-370,100,000.00
Net Margins: -31.99%
Pretax Margin: -21.86%
Return on Equity: -23.38%
Return on Assets: -8.89%

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 0.90
Quick Ratio: 0.42

Sales & Book Value

Annual Sales: $1.34 billion
Price / Sales: 2.01
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.07 per share
Price / Book: 2.05

Miscellaneous

Outstanding Shares: 630,940,000
Free Float: N/A
Market Cap: $2.68 billion
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Boris Alexis Jordan (Age 57)
Exec. Chairman
Comp: $1.75M

Mr. Matthew S. Darin
Chief Exec. Officer

Mr. Joseph F. Lusardi (Age 49)
Exec. Vice-Chairman
Comp: $657.7k

Mr. Edward Kremer (Age 51)
Chief Financial Officer
Comp: $461.74k

Mr. Joe Holland
Exec. VP of Operations

Mr. Camilo Russi Lyon
Chief Investment Officer

Mr. Jakob Feinstein
Mang. of Investor Relations

Mr. Peter Laurence Clateman J.D. (Age 55)
Chief Legal Officer

Mr. James S. Shorris (Age 61)
Chief Compliance Officer

Ms. Tracy Brady
Sr. VP of Corp. Communications

Key Competitors

View All Competitors

CURLF Stock - Frequently Asked Questions

Should I buy or sell Curaleaf stock right now?: 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 1 sell rating, 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CURLF shares.
View CURLF analyst ratings or view top-rated stocks.
What is Curaleaf's stock price forecast for 2023?: 11 Wall Street analysts have issued 1 year price targets for Curaleaf's shares. Their CURLF share price forecasts range from $4.25 to $32.25. On average, they expect the company's stock price to reach $13.00 in the next year. This suggests a possible upside of 205.9% from the stock's current price.
View analysts price targets for CURLF or view top-rated stocks among Wall Street analysts.
How have CURLF shares performed in 2023?: Curaleaf's stock was trading at $4.2973 at the beginning of the year. Since then, CURLF stock has decreased by 1.1% and is now trading at $4.25.
View the best growth stocks for 2023 here.
Are investors shorting Curaleaf?: Curaleaf saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 2,729,600 shares, a decline of 13.0% from the August 31st total of 3,136,900 shares. Based on an average trading volume of 2,810,700 shares, the short-interest ratio is presently 1.0 days.
View Curaleaf's Short Interest.
How were Curaleaf's earnings last quarter?: Curaleaf Holdings, Inc. (OTCMKTS:CURLF) released its quarterly earnings data on Wednesday, August, 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.03. The business had revenue of $338.58 million for the quarter, compared to the consensus estimate of $339.02 million. Curaleaf had a negative trailing twelve-month return on equity of 23.38% and a negative net margin of 31.99%.

What is Curaleaf's stock symbol?: Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF."
How do I buy shares of Curaleaf?: Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Curaleaf's stock price today?: One share of CURLF stock can currently be purchased for approximately $4.25.
How much money does Curaleaf make?: Curaleaf (OTCMKTS:CURLF) has a market capitalization of $2.68 billion and generates $1.34 billion in revenue each year. The company earns $-370,100,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.
How many employees does Curaleaf have?: The company employs 5,931 workers across the globe.
How can I contact Curaleaf?: Curaleaf's mailing address is 301 Edgewater Place, Wakefield, MA 01880. The official website for the company is www.curaleaf.com. The company can be reached via phone at 781-451-0351 or via email at ir@curaleaf.com.

This page (OTCMKTS:CURLF) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial